Home LiteratureArticle Details
PMID: 8325978 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.

The Journal of clinical investigation ·Vol. 92 ·No. 1 ·1993-07-00 ·Pages 141-6

Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM

Abstract

Subjects characterized by a predominance of small LDL particles (pattern B) have changes in plasma triglyceride (TG) and HDL-cholesterol concentrations consistent with the presence of resistance to insulin-mediated glucose uptake. To pursue this issue, plasma glucose and insulin responses to oral glucose, insulin-mediated glucose disposal, and lipoprotein concentrations were measured in subjects categorized on the basis of LDL peak diameter measured by gradient gel electrophoresis. Subjects with pattern B had higher (P < 0.05-0.001) total integrated plasma glucose (20.7 +/- 1.0 mmol/liter.h) and insulin (1,743 +/- 293 pmol/liter.h) responses to oral glucose compared with glucose (16.3 +/- 0.4 and 19.2 +/- 0.8 mmol/liter.h) and insulin (856 +/- 60 and 1,222 +/- 168 pmol/liter.h) responses in those with either pattern A or an intermediate pattern. Pattern B individuals were shown to be more insulin resistant on the basis of higher steady state plasma glucose concentrations (SSPG, 10.4 +/- 1.0, P < 0.002, vs. 7.5 +/- 0.7 and 6.0 +/- 0.4 mmol/liter) after a constant infusion of somatostatin, glucose, and insulin than those with either the intermediate or pattern A subclass. Pattern B subjects also had higher concentrations of (P < 0.001) TG (1.98 +/- 0.15 vs. 1.33 +/- 0.17 and 0.77 +/- 0.05 mmol/liter) and lower (P < 0.01-0.001) HDL cholesterol (1.12 +/- 0.06 vs. 1.34 +/- 0.05 vs. 1.45 +/- 0.05 mmol/liter) than those with either the intermediate or pattern A. Finally, significant (P < 0.001) correlation coefficients existed between LDL diameter and SSPG (r = -0.44); glucose (r = -0.41) and insulin (r = -0.38) responses; TG (r = -0.65) and HDL-cholesterol (r = 0.42) concentrations; and systolic (r = -0.34) and diastolic (r = -0.34) blood pressure. Thus, pattern B subjects are insulin resistant, have higher glucose, insulin, and TG, lower HDL-cholesterol levels, and higher blood pressure than those with pattern A or intermediate.

MeSH Terms
Adult Blood Glucose/metabolism Body Mass Index Female Humans Insulin Resistance Lipids/blood Lipoproteins, LDL/blood,ultrastructure Male Middle Aged
Chemicals
Blood Glucose Lipids Lipoproteins, LDL
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Reaven G M
Department of Medicine, Stanford University School of Medicine, California.
Chen Y D
Jeppesen J
Maheux P
Krauss R M
References (28)
28 references, click to expand
  1. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis.
    Am J Hum Genet. 1988 Dec;43(6):838-46 PMID: 3195585
  2. Immunoassay of insulin with insulin-antibody precipitate.
    Biochem J. 1963 Jul;88:137-46 PMID: 13952078
  3. Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension.
    Am J Med. 1989 Jan 23;86(1B):14-8 PMID: 2643861
  4. Role of insulin in endogenous hypertriglyceridemia.
    J Clin Invest. 1967 Nov;46(11):1756-67 PMID: 6061748
  5. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes.
    J Clin Invest. 1970 Dec;49(12):2151-60 PMID: 5480843
  6. Measurements of the molecular weight variability of plasma low density lipoproteins among normals and subjects with hyper- -lipoproteinemia. Demonstration of macromolecular heterogeneity.
    Biochemistry. 1972 Feb 15;11(4):519-25 PMID: 4334903
  7. Enzymatic determination of total serum cholesterol.
    Clin Chem. 1974 Apr;20(4):470-5 PMID: 4818200
  8. Reappraisal of the role of insulin in hypertriglyceridemia.
    Am J Med. 1974 Oct;57(4):551-60 PMID: 4372881
  9. Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
    J Lipid Res. 1982 Jan;23(1):97-104 PMID: 7057116
  10. Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men.
    Diabetologia. 1981 Dec;21(6):544-8 PMID: 7040144
  11. Are the binding and degradation of low density lipoprotein altered in Type 2 (non-insulin-dependent) diabetes mellitus?
    Diabetologia. 1982 Jul;23(1):28-33 PMID: 7117726
  12. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease.
    J Lipid Res. 1985 May;26(5):566-74 PMID: 4020295
  13. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.
    Lancet. 1987 Jul 11;2(8550):62-6 PMID: 2885572
  14. Resistance to insulin-stimulated-glucose uptake in patients with hypertension.
    J Clin Endocrinol Metab. 1988 Mar;66(3):580-3 PMID: 3350907
  15. Low-density lipoprotein subclass patterns and risk of myocardial infarction.
    JAMA. 1988 Oct 7;260(13):1917-21 PMID: 3418853
  16. Banting lecture 1988. Role of insulin resistance in human disease.
    Diabetes. 1988 Dec;37(12):1595-607 PMID: 3056758
  17. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulin.
    Thromb Haemost. 1989 Jun 30;61(3):370-3 PMID: 2678583
  18. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease.
    J Intern Med. 1990 Apr;227(4):273-8 PMID: 2182759
  19. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
    JAMA. 1990 Jun 6;263(21):2893-8 PMID: 2338751
  20. High plasma insulin and triglyceride concentrations and blood pressure in offspring of people with impaired glucose tolerance.
    Diabet Med. 1990 Jul;7(6):494-8 PMID: 2142051
  21. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.
    Arteriosclerosis. 1990 Jul-Aug;10(4):520-30 PMID: 2369363
  22. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.
    Circulation. 1990 Aug;82(2):495-506 PMID: 2372896
  23. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
    Diabetologia. 1991 Jun;34(6):416-22 PMID: 1884900
  24. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis.
    Diabetologia. 1991 Jul;34(7):457-62 PMID: 1916049
  25. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19.
    Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):708-12 PMID: 1731344
  26. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations.
    J Intern Med. 1992 Jan;231(1):25-30 PMID: 1732395
  27. Altering triglyceride concentrations changes insulin-glucose relationships in hypertriglyceridemic patients. Double-blind study with gemfibrozil with implications for atherosclerosis.
    Diabetes Care. 1991 Nov;14(11):1077-81 PMID: 1797490
  28. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.
    JAMA. 1991 Dec 4;266(21):3008-11 PMID: 1820474
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1993-07-00
Pages
141-6
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC293550
Subset
IM
Grants
NHLBI NIH HHS · HL 08506 · United States
NHLBI NIH HHS · HL 18574 · United States
NCRR NIH HHS · RR 00070 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]